Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theriva Biologics

0.3124
-0.0116-3.58%
Post-market: 0.3120-0.0004-0.13%19:59 EDT
Volume:3.58M
Turnover:1.10M
Market Cap:10.54M
PE:-0.04
High:0.3199
Open:0.3184
Low:0.3003
Close:0.3240
52wk High:2.64
52wk Low:0.2830
Shares:33.74M
Float Shares:33.73M
Volume Ratio:0.03
T/O Rate:10.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.7644
EPS(LYR):-19.0286
ROE:-154.45%
ROA:-42.17%
PB:0.99
PE(LYR):-0.02

Loading ...

Theriva Biologics Inc. Announces Date for Upcoming Special Stockholders Meeting

Reuters
·
7 hours ago

Theriva Biologics: No Material Development to Account for Stock Activity

Dow Jones
·
Oct 25

Theriva Biologics sees no material development to account for unusual trading

TIPRANKS
·
Oct 25

Theriva Biologics Provides Response to Unusual Market Action

GlobeNewswire
·
Oct 25

Theriva Biologics Presents Promising Phase 2b Trial Data

TIPRANKS
·
Oct 21

Theriva Biologics Secures $4M Through Warrant Agreement

TIPRANKS
·
Oct 18

Theriva Biologics Raises $4 Million Through Warrant Inducement Private Placement

Reuters
·
Oct 18

Theriva Biologics announces warrant inducement transaction for $4M in proceeds

TIPRANKS
·
Oct 16

Theriva Biologics Announces New Preclinical Data and Next-Generation Oncolytic Adenovirus VCN-12 at ESGCT Congress, Highlighting Advances in Cancer Treatment

Reuters
·
Oct 06

Theriva Biologics Restructures, Cuts Workforce by 32%

TIPRANKS
·
Oct 03

BRIEF-Theriva Biologics Implements 32% Workforce Reduction - SEC Filing

Reuters
·
Oct 03

Theriva Biologics Inc: Expects Will Extend Its Cash Runway Into Q2 of 2026

THOMSON REUTERS
·
Oct 03

Theriva Biologics Announces Corporate Reorganization, Cuts Workforce by 32% to Focus on Clinical Trials and Licensing Activities

Reuters
·
Oct 03

Theriva Biologics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Sep 05

Theriva Biologics Q2 EPS $(1.93) Misses $(1.08) Estimate

Benzinga
·
Aug 11

Theriva Biologics Inc: Q2 EPS $-1.93

THOMSON REUTERS
·
Aug 11

Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results

THOMSON REUTERS
·
Aug 11

Theriva Biologics Inc. Files Prospectus for Offering Up to $2.5 Million in Common Stock

Reuters
·
Jun 21

BRIEF-Theriva™ Biologics Announces Presentation Of Data From Vcn-01 Retinoblastoma Phase 1 Clinical Trial At Asco 2025

Reuters
·
May 27

Theriva Biologics Q1 EPS $(1.55) Up From $(7.53) YoY

Benzinga
·
May 14